Binding sequence-dependent regulation of the human proliferating cell nuclear antigen promoter by p53

Experimental Cell Research

Volumn 305, Issue 1, 2005, Pages 10-22

  Shan, Bin ^a   Morris, Gilbert F ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA damage; DNA binding site; Ionizing radiation; p21 WAF1; p53; PCNA; Promoter; Transcription regulation

Indexed keywords

ALANINE; AMINO ACID; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLINE; PROTEIN P21; PROTEIN P53; SERINE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL PROLIFERATION; DNA BINDING; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DRUG MEGADOSE; HUMAN; HUMAN CELL; IN VITRO STUDY; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; WILD TYPE;

EID: 15044338548     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.09.033     Document Type: Article

References (79)

1. M. Hollstein, K. Rice, M.S. Greenblatt, T. Soussi, R. Fuchs, T. Sorlie, E. Hovig, B. Smith-Sorensen, R. Montesano, and C.C. Harris Database of p53 gene somatic mutations in human tumors and cell lines Nucleic Acids Res. 22 1994 3551 3555
2. M. Harvey, H. Vogel, D. Morris, A. Bradley, A. Bernstein, and L.A. Donehower A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice Nat. Genet. 9 1995 305 311
3. M. Oren Decision making by p53: life, death and cancer Cell Death Differ. 10 2003 431 442
4. K.H. Vousden Activation of the p53 tumor suppressor protein Biochim. Biophys. Acta 1602 2002 47 59
5. W.S. el-Deiry, S.E. Kern, J.A. Pietenpol, K.W. Kinzler, and B. Vogelstein Definition of a consensus binding site for p53 Nat. Genet. 1 1992 45 49
6. E. Appella, and C.W. Anderson Post-translational modifications and activation of p53 by genotoxic stresses Eur. J. Biochem. 268 2001 2764 2772
7. C.L. Brooks, and W. Gu Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation Curr. Opin. Cell Biol. 15 2003 164 171
8. W.S. el-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
9. H. Hermeking, C. Lengauer, K. Polyak, T.C. He, L. Zhang, S. Thiagalingam, K.W. Kinzler, and B. Vogelstein 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression Mol. Cell 1 1997 3 11
10. T. Miyashita, and J.C. Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293 299
11. K. Oda, H. Arakawa, T. Tanaka, K. Matsuda, C. Tanikawa, T. Mori, H. Nishimori, K. Tamai, T. Tokino, Y. Nakamura, and Y. Taya p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53 Cell 102 2000 849 862
12. K. Nakano, and K.H. Vousden PUMA, a novel proapoptotic gene, is induced by p53 Mol. Cell 7 2001 683 694
13. G.S. Wu, T.F. Burns, E.R. McDonald III, W. Jiang, R. Meng, I.D. Krantz, G. Kao, D.D. Gan, J.Y. Zhou, R. Muschel, S.R. Hamilton, N.B. Spinner, S. Markowitz, G. Wu, and W.S. el-Deiry KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene Nat. Genet. 17 1997 141 143
14. K.H. Vousden p53: death star Cell 103 2000 691 694
15. X. Chen, L.J. Ko, L. Jayaraman, and C. Prives p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells Genes Dev. 10 1996 2438 2451
16. J.D. Weber, and G.P. Zambetti Renewing the debate over the p53 apoptotic response Cell Death Differ. 10 2003 409 412
17. E.A. Slee, D.J. O'Connor, and X. Lu To die or not to die: how does p53 decide? Oncogene 23 2004 2809 2818
18. H. Tanaka, H. Arakawa, T. Yamaguchi, K. Shiraishi, S. Fukuda, K. Matsui, Y. Takei, and Y. Nakamura A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage Nature 404 2000 42 49
19. M.L. Smith, I.T. Chen, Q. Zhan, I. Bae, C.Y. Chen, T.M. Gilmer, M.B. Kastan, P.M. O'Connor, and A.J. Fornace Jr. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen Science 266 1994 1376 1380
20. E. Warbrick The puzzle of PCNA's many partners BioEssays 22 2000 997 1006
21. S. Tommasi, and G.P. Pfeifer In vivo structure of two divergent promoters at the human PCNA locus. Synthesis of antisense RNA and S phase-dependent binding of E2F complexes in intron 1 J. Biol. Chem. 274 1999 27829 27838
22. D. Jaskulski, C. Gatti, S. Travali, B. Calabretta, and R. Baserga Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors J. Biol. Chem. 263 1988 10175 10179
23. H.W. Chang, Y.C. Lai, C.Y. Cheng, J.L. Ho, S.T. Ding, and Y.C. Liu UV inducibility of rat proliferating cell nuclear antigen gene promoter J. Cell. Biochem. 73 1999 423 432
24. J. Xu, and G.F. Morris p53-mediated regulation of proliferating cell nuclear antigen expression in cells exposed to ionizing radiation Mol. Cell. Biol. 19 1999 12 20
25. P. Jackson, P. Ridgway, J. Rayner, J. Noble, and A. Braithwaite Transcriptional regulation of the PCNA promoter by p53 Biochem. Biophys. Res. Commun. 203 1994 133 140
26. C.V. Shivakumar, D.R. Brown, S. Deb, and S.P. Deb Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter Mol. Cell. Biol. 15 1995 6785 6793
27. M.A. Subler, D.W. Martin, and S. Deb Inhibition of viral and cellular promoters by human wild-type p53 J. Virol. 66 1992 4757 4762
28. W.E. Mercer, M.T. Shields, D. Lin, E. Appella, and S.J. Ullrich Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression Proc. Natl. Acad. Sci. U. S. A. 88 1991 1958 1962
29. G.F. Morris, J.R. Bischoff, and M.B. Mathews Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53 Proc. Natl. Acad. Sci. U. S. A. 93 1996 895 899
30. A. Inga, F. Storici, T.A. Darden, and M.A. Resnick Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence Mol. Cell. Biol. 22 2002 8612 8625
31. Y. Wang, and C. Prives Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases Nature 376 1995 88 91
32. L. Resnick-Silverman, S. St Clair, M. Maurer, K. Zhao, and J.J. Manfredi Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53 Genes Dev. 12 1998 2102 2107
33. E.C. Thornborrow, and J.J. Manfredi One mechanism for cell type-specific regulation of the bax promoter by the tumor suppressor p53 is dictated by the p53 response element J. Biol. Chem. 274 1999 33747 33756
34. B. Shan, J. Xu, Y. Zhuo, C.A. Morris, and G.F. Morris Induction of p53-dependent activation of the PCNA gene in chromatin by ionizing radiation J. Biol. Chem. 278 2003 44009 44017
35. C. Cayrol, M. Knibiehler, and B. Ducommun p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells Oncogene 16 1998 311 320
36. G.F. Morris, and M.B. Mathews Analysis of the proliferating cell nuclear antigen promoter and its response to adenovirus early region 1 J. Biol. Chem. 265 1990 16116 16125
37. L. Diller, J. Kassel, C.E. Nelson, M.A. Gryka, G. Litwak, M. Gebhardt, B. Bressac, M. Ozturk, S.J. Baker, and B. Vogelstein p53 functions as a cell cycle control protein in osteosarcomas Mol. Cell. Biol. 10 1990 5772 5781
38. R.R. Spaete, and E.S. Mocarski Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts J. Virol. 56 1985 135 143
39. T.R. Brummelkamp, R. Bernards, and R. Agami A system for stable expression of short interfering RNAs in mammalian cells Science 296 2002 550 553
40. G.F. Morris, C. Labrie, and M.B. Mathews Modulation of transcriptional activation of the proliferating cell nuclear antigen promoter by the adenovirus E1A 243-residue oncoprotein depends on proximal activators Mol. Cell. Biol. 14 1994 543 553
41. J.P. Goldring, and L. Ravaioli Solubilization of protein-dye complexes on nitrocellulose to quantify proteins spectrophotometrically Anal. Biochem. 242 1996 197 201
42. S.M. Hassur, and H.W. Whitlock Jr. UV shadowing-a new and convenient method for the location of ultraviolet-absorbing species in polyacrylamide gels Anal. Biochem. 59 1974 162 164
43. A.P. Feinberg, and B. Vogelstein A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity Addendum Anal. Biochem. 137 1984 266 267
44. V. Radha, C. Sudhakar, and G. Swarup Induction of p53 dependent apoptosis upon overexpression of a nuclear protein tyrosine phosphatase FEBS Lett. 453 1999 308 312
45. J.R. Noble, K.E. Willetts, W.E. Mercer, and R.R. Reddel Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53 Exp. Cell Res. 203 1992 297 304
46. A. Di Leonardo, S.P. Linke, K. Clarkin, and G.M. Wahl DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts Genes Dev. 8 1994 2540 2551
47. M. Mundt, T. Hupp, M. Fritsche, C. Merkle, S. Hansen, D. Lane, and B. Groner Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential Oncogene 15 1997 237 244
48. T.R. Hupp, D.W. Meek, C.A. Midgley, and D.P. Lane Regulation of the specific DNA binding function of p53 Cell 71 1992 875 886
49. E. Kim, G. Rohaly, S. Heinrichs, D. Gimnopoulos, H. Meissner, and W. Deppert Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53 Oncogene 18 1999 7310 7318
50. J.M. Espinosa, and B.M. Emerson Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment Mol. Cell 8 2001 57 69
51. G. Maga, and U. Hubscher Proliferating cell nuclear antigen (PCNA): a dancer with many partners J. Cell Sci. 116 2003 3051 3060
52. R. Zhao, K. Gish, M. Murphy, Y. Yin, D. Notterman, W.H. Hoffman, E. Tom, D.H. Mack, and A.J. Levine Analysis of p53-regulated gene expression patterns using oligonucleotide arrays Genes Dev. 14 2000 981 993
53. V. Di Stefano, C. Rinaldo, A. Sacchi, S. Soddu, and G. D'Orazi Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis Exp. Cell Res. 293 2004 311 320
54. T. Ando, T. Kawabe, H. Ohara, B. Ducommun, M. Itoh, and T. Okamoto Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage J. Biol. Chem. 276 2001 42971 42977
55. V. Chopin, R.A. Toillon, N. Jouy, and X. Le Bourhis P21(WAF1/CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells Oncogene 23 2004 21 29
56. R. Li, S. Waga, G.J. Hannon, D. Beach, and B. Stillman Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair Nature 371 1994 534 537
57. M.P. Cooper, A.S. Balajee, and V.A. Bohr The C-terminal domain of p21 inhibits nucleotide excision repair in vitro and In vivo Mol. Biol. Cell 10 1999 2119 2129
58. Z.Q. Pan, J.T. Reardon, L. Li, H. Flores-Rozas, R. Legerski, A. Sancar, and J. Hurwitz Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21 J. Biol. Chem. 270 1995 22008 22016
59. A.S. Balajee, and C.R. Geard Chromatin-bound PCNA complex formation triggered by DNA damage occurs independent of the ATM gene product in human cells Nucleic Acids Res. 29 2001 1341 1351
60. P. Karmakar, A.S. Balajee, and A.T. Natarajan Analysis of repair and PCNA complex formation induced by ionizing radiation in human fibroblast cell lines Mutagenesis 16 2001 225 232
61. S. Matsuoka, M. Yamaguchi, and A. Matsukage D-type cyclin-binding regions of proliferating cell nuclear antigen J. Biol. Chem. 269 1994 11030 11036
62. T. Kawabe, M. Suganuma, T. Ando, M. Kimura, H. Hori, and T. Okamoto Cdc25C interacts with PCNA at G2/M transition Oncogene 21 2002 1717 1726
63. M. Scott, P. Bonnefin, D. Vieyra, F.M. Boisvert, D. Young, D.P. Bazett-Jones, and K. Riabowol UV-induced binding of ING1 to PCNA regulates the induction of apoptosis J. Cell Sci. 114 2001 3455 3462
64. S. Tournier, D. Leroy, F. Goubin, B. Ducommun, and J.S. Hyams Heterologous expression of the human cyclin-dependent kinase inhibitor p21Cip1 in the fission yeast, Schizosaccharomyces pombe reveals a role for PCNA in the chk1+cell cycle checkpoint pathway Mol. Biol. Cell 7 1996 651 662
65. S.-Y. Kao, and S.J. Marriott Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 Tax protein J. Virol. 73 1999 4299 4304
66. D. Jaskulski, C. Gatti, S. Travali, B. Calabretta, and R. Baserga Regulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors J. Biol. Chem. 263 1988 10175 10179
67. T. Gohler, M. Reimann, D. Cherny, K. Walter, G. Warnecke, E. Kim, and W. Deppert Specific interaction of p53 with target binding sites is determined by DNA conformation and is regulated by the C-terminal domain J. Biol. Chem. 277 2002 41192 41203
68. J. Luo, M. Li, Y. Tang, M. Laszkowska, R.G. Roeder, and W. Gu Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo Proc. Natl. Acad. Sci. U. S. A. 101 2004 2259 2264
69. E. Kim, and W. Deppert The complex interactions of p53 with target DNA: we learn as we go Biochem. Cell Biol. 81 2003 141 150
70. M.D. Kaeser, and R.D. Iggo Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo Proc. Natl. Acad. Sci. U. S. A. 99 2002 95 100
71. S.T. Szak, D. Mays, and J.A. Pietenpol Kinetics of p53 binding to promoter sites in vivo Mol. Cell. Biol. 21 2001 3375 3386
72. J.M. Espinosa, R.E. Verdun, and B.M. Emerson p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage Mol. Cell 12 2003 1015 1027
73. M.D. Kaeser, and R.D. Iggo Promoter-specific p53-dependent histone acetylation following DNA damage Oncogene 23 2004 4007 4013
74. Y. Samuels-Lev, D.J. O'Connor, D. Bergamaschi, G. Trigiante, J.K. Hsieh, S. Zhong, I. Campargue, L. Naumovski, T. Crook, and X. Lu ASPP proteins specifically stimulate the apoptotic function of p53 Mol. Cell 8 2001 781 794
75. D. Dornan, H. Shimizu, L. Burch, A.J. Smith, and T.R. Hupp The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53 Mol. Cell. Biol. 23 2003 8846 8861
76. D. Dornan, H. Shimizu, N.D. Perkins, and T.R. Hupp DNA-dependent acetylation of p53 by the transcription coactivator p300 J. Biol. Chem. 278 2003 13431 13441
77. F.E. Chen-Park, D.B. Huang, B. Noro, D. Thanos, and G. Ghosh The kappa B DNA sequence from the HIV long terminal repeat functions as an allosteric regulator of HIV transcription J. Biol. Chem. 277 2002 24701 24708
78. T.H. Leung, A. Hoffmann, and D. Baltimore One nucleotide in a kappa B site can determine cofactor specificity for NF-kappa B dimers Cell 118 2004 453 464
79. N. Brunner, D. Yee, G. Kern, M. Spang-Thomsen, M.E. Lippman, and K.J. Cullen Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II) Eur. J. Cancer 29A 1993 562 569